Skip to main content

Advertisement

Table 1 Baseline characteristics of 123 CHB patients treated with bicyclol tablets

From: Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience

Variables All patients (n = 123) Normal ALT (n = 38) Elevated ALT (n = 85)
Demographic characteristics
 Median age, years (range) 35 (18–65) 39 (23–61) 33 (18–65)
 Males, n (%) 85 (69.1) 25 (65.8) 60 (70.6)
Laboratory data
 Median ALT, U/L (range) 68.0 (5–483) 24.5 (5–50) 98 (51–483)
 Median AST, U/L (range) 44.0 (15–323) 23.0 (15–40) 56 (27–323)
 HBeAg (+), n (%) 66 (53.7) 9 (23.7) 57 (67.1)
 HBV DNA (mean ± SD), log10IU/ml 5.99 ± 1.76 4.43 ± 1.79 6.67 ± 1.24
Liver histology
 Inflammation activity, n (%)
  G2, n (%) 61 (87.1) 20 (80.0) 41 (91.1)
  G3, n (%) 9 (12.9) 5 (20.0) 4 (8.9)
 Fibrosis (%)
  S1, n (%) 22 (31.4) 7 (28.0) 15 (33.3)
  S2, n (%) 37 (52.8) 11 (44.0) 26 (57.8)
  S3, n (%) 11 (15.8) 7 (28.0) 4 (8.9)